Trending 
The acting head of the United States (US) Food and Drug Administration’s drug centre, Tracy Beth Hoeg, was sacked on Friday.
Hoeg disclosed the news in a post via her social media page. She has been replaced by Deputy Michael Davis, as displayed on the FDA website.
Based on reports, Hoeg’s departure comes shortly after broader leadership changes at the agency, including the replacement of FDA Commissioner Marty Makary.
Recall that Kyle Diamantas, who had been the FDA deputy commissioner for food, replaced Makary, who exited after weeks of clashing with top White House and health advisers over a series of decisions that drew criticism regarding drug approvals and other areas.
Michael Davis, who previously served as deputy director of the Centre for Drug Evaluation and Research, is now the acting head of the drug division. Other changes were also announced across the agency.
Also, Karim Mikhail has been named acting head of the Centre for Biologics Evaluation and Research, while Lowell Zeta has become acting chief of staff. Officials say the changes are part of a broader restructuring of the FDA, which has seen staff reductions and departures since President Donald Trump took office.
Hoeg is an epidemiologist and sports physician who previously questioned COVID-19 vaccines during the pandemic. She had also worked on proposals to change the U.S. childhood vaccination schedule, reducing the number of recommended vaccines, though the plan was later paused by a court.
The White House has also been involved in reshaping leadership across U.S. health agencies, including the CDC and Surgeon General positions.
